Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0044 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
filingDate |
1984-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1986-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90632a2751d596036dc34f7dabdb25f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c6658498cb524cea72a6c6f477086d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9d984f8663c23f30291fb37877e1a7 |
publicationDate |
1986-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4609650-A |
titleOfInvention |
Double ester of 16β-ethylestran-17β-ol derivatives |
abstract |
A novel steroid compound of the formula <IMAGE> (I) wherein A is a lower alkylene group; <IMAGE> is an acyl group; and is a single bond or a double bond, and methods of producing the compound (I) as follows: <IMAGE> (1) <IMAGE> (2) <IMAGE> (3) and a pharmaceutical composition containing the compound (I). The compound (I) exhibits excellent antiandrogenic activity on oral administration and can be used for the treatment of prostatic hypertrophy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5254718-A |
priorityDate |
1983-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |